Skip to main content
. 2019 Nov 27;24:99. doi: 10.4103/jrms.JRMS_83_19

Table 2.

Laboratory characteristics of patients with systemic lupus erythematosus and healthy controls

SLE patients (n=49) Healthy controls (n=50) P
ESR (mm/h) 52.3±35.4 15.6±6.9 0.0001
CRP (mg/l) 15.4±17.4 4.2±2.6 0.0001
RF, positive 3 (6.2) 0 0.119
White blood cell (109/l) 6.2±2.7 6.8±1.7 0.119
Hemoglobin 11.1±0.62 14.3±1.5 0.0001
PLT (109/l) 197.1±84.2 233.4±66.7 0.019
BUN 22.2±17.9 15.8±4.5 0.018
Creatinine (mg/dL) 1.39±1.81 0.87±0.21 0.046
FBS 89.7±20.4 98.1±42.5 0.214
HDL 52.4±13.5 47.5±12.0 0.059
LDL 100.7±24.1 106.2±38.8 0.335
TG 156.3±56.6 147.9±69.8 0.463
Anti-dsDNA (IU/mL) 197.7±208.8 8.9±4.4 0.0001
 Negative (<20) 6 (12.2) 49 (100) 0.0001
 Positive (>20) 43 (87.8) 0
C3 (mg/dL) 45.7±48.7 137.8±6.4 0.0001
 <90 41 (83.7) 0 -
 ≥90 8 (16.3) 50 (100)
C4 (mg/dL) 10.4±10.1 16.3±4.8 0.0001
 <10 39 (79.6) 0 -
 ≥10 10 (20.4) 50 (100)

Data are mean±SD, or n (%). P values were calculated using independent sample t-test or Chi-square test. SLE=Systemic lupus erythematosus; SD=Standard deviation; ESR=Erythrocyte sedimentation rate; CRP=C-reactive protein; RF=Rheumatoid factor; BUN=Blood urea nitrogen; PLT=Platelet; HDL=High-density lipoprotein; LDL=Low-density lipoprotein; TG=Triglyceride; FBS=Fasting blood sugar; C3=Complement component 3; C4=Complement component 4; dsDNA=Double-stranded DNA